一个患有严重甲基马龙酸血症的妇女的成功怀孕管理
M Woidy1,2, K Tsiakas1,2, M Mahmud3,4
1Department for Inborn Metabolic Diseases University Children's Hospital, University Medical Center Hamburg-Eppendorf Hamburg Germany.
JIMD reports
|May 14, 2025
概括
患有严重甲基马龙酸血症 (MMA) 和慢性病 (CKD) 的女性怀孕是具有挑战性的,但可以实现的. 这一案例显示了一位患有mut0缺乏症和末期脏疾病 (ESRD) 的母亲的成功管理和结果.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 孤立的甲基马龙酸血症 (MMA) 包含由于甲基马龙-CoA突变酶 (MMUT),腺索基巴胺代谢或甲基马龙-CoA表酶缺乏的罕见代谢障碍.
- 越来越多的MMA女性正在达到生育年龄,在较温和的形式中报告了成功怀孕.
- 严重的mut0缺陷与晚期慢性病 (CKD) 结合,在怀孕期间会带来独特的挑战.
研究的目的:
- 报告严重突变缺陷和末期脏疾病 (ESRD) 的患者怀孕的管理和结果.
- 突出在复杂的MMA案件中成功怀孕所需的跨学科方法.
主要方法:
- 病例报告详细介绍了患有严重mut0缺乏症和ESRD需要血液透析的妇女的怀孕管理.
- 密切监测母亲的新陈代谢状态和胎儿发育,包括对胎儿生长限制 (FGR) 的超声波.
- 营养调整和及时的置换疗法是护理的关键组成部分.
主要成果:
- 由于ESRD,患者从怀孕21周开始接受了血液透析.
- 在20周发现胎儿生长限制 (FGR),需要密集监测和饮食管理.
- 一个健康的新生儿在35周通过剖腹产分娩,带有轻微的先天异常.
- 母亲经历了轻微的产后代谢去补偿,通过额外的替代疗法成功管理.
- 产后3个月,母亲和孩子都很好,没有进一步的代谢并发症.
结论:
- 怀孕在严重的突变缺陷与晚期CKD是可行的,但需要细致的,跨学科的管理.
- 早期诊断,主动监测和量身定制的干预措施可以带来有利的孕产妇和胎儿结果.
- 这一案例强调了为孕妇患有罕见代谢障碍和损害的孕妇提供专业护理的重要性.
相关概念视频
Inborn Errors of Metabolism
115
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
115
Chronic Pancreatitis II: Collaborative Care
50
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
50
Phase II Reactions: Methylation Reactions
100
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
100
Diabetes: Management and Pharmacotherapy
214
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
214


